SkylineDx's MMprofiler receives CE-IVD certification

November 25, 2015

SkylineDx, today announced they have received CE-IVD registration from the European Competent Authority (Ministry of Health) for the MMprofiler, the company's prognostic test to determine the level of risk of a patient with multiple myeloma (MM).

Previous Article
Allergan, Rugen Therapeutics collaborate to discover and develop novel therapies for ASD and OCD
Allergan, Rugen Therapeutics collaborate to discover and develop novel therapies for ASD and OCD

Allergan plc, a leading global pharmaceutical company, and Rugen Therapeutics, a start-up biotechnology com...

Next Article
Healthcare Habits Die Hard [Page 3.14]
Healthcare Habits Die Hard [Page 3.14]

As the U.S. seeks to drive down medical spending, one goal is to eliminate tests and treatments that are in...